Axogen
Open
$42.98
Prev. Close
$42.99
High
$42.99
Low
$42.98
Market Snapshot
$2.17B
-68.9
-0.22
$187.34M
622
Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. The company is headquartered in Alachua, Florida and currently employs 622 full-time employees. The company offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.
emptyResult
Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. The company is headquartered in Alachua, Florida and currently employs 622 full-time employees. The company offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.
Recently from Cashu
Axogen Reports Strong Q4 Growth Driven by Innovative Nerve Repair Product Launches
Axogen Sees Robust Q4 Growth Amid Innovative Product Launches Axogen (NASDAQ: AXGN) demonstrates impressive financial progress in its recently announced Q4 earnings report. The company reports a total…
Divergent Analyst Views on Axogen Highlight Execution and Reimbursement Risks
Divergent analyst readings spotlight Axogen’s execution and reimbursement risks Axogen is facing a sharp divergence in analyst assessments this quarter as six independent research firms issue ratings…
Analysts Split on Axogen’s Clinical and Reimbursement Trajectory
Analysts’ Divergence Casts Spotlight on Axogen’s Clinical and Reimbursement Path A split among six independent analysts this quarter places a clear focus on Axogen’s underlying clinical and commercial…
Axogen Receives FDA Approval for Avance, Enhancing Peripheral Nerve Repair Solutions
Axogen Secures FDA Approval for Avance, Advancing Peripheral Nerve Repair Options Axogen Inc. recently achieves a significant milestone with the U.S. Food and Drug Administration's (FDA) approval of i…